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Introduction: NASA is contemplating future human exploration missions to destinations beyond low 
Earth orbit, including the Moon, deep-space asteroids, and Mars. While we have learned much about 
protecting crew health and performance during orbital space flight over the past half-century, the 
challenges of these future missions far exceed those within our current experience base. To ensure success 
in these missions, we have developed a Human System Risk Board (HSRB) to identify, quantify, and 
develop mitigation plans for the extraordinary risks associated with each potential mission scenario. The 
HSRB comprises research, technology, and operations experts in medicine, physiology, psychology, 
human factors, radiation, toxicology, microbiology, pharmacology, and food sciences. Methods: Owing 
to the wide range of potential mission characteristics, we first identified the hazards to human health and 
performance common to all exploration missions: altered gravity, isolation/confinement, increased 
radiation, distance from Earth, and hostile/closed environment. Each hazard leads to a set of risks to crew 
health and/or performance. For example the radiation hazard leads to risks of acute radiation syndrome, 
central nervous system dysfunction, soft tissue degeneration, and carcinogenesis. Some of these risks 
(e.g., acute radiation syndrome) could affect crew health or performance during the mission, while others 
(e.g., carcinogenesis) would more likely affect the crewmember well after the mission ends. We next 
defined a set of design reference missions (DRM) that would span the range of exploration missions 
currently under consideration. In addition to standard (6-month) and long-duration (1-year) missions in 
low Earth orbit (LEO), these DRM include deep space sortie missions of 1 month duration, lunar orbital 
and landing missions of 1 year duration, deep space journey and asteroid landing missions of 1 year 
duration, and Mars orbital and landing missions of 3 years duration. We then assessed the likelihood and 
consequences of each risk against each DRM, using three levels of likelihood (Low: ≤0.1%; Medium: 
0.1%–1.0%; High: ≥1.0%) and four levels of consequence ranging from Very Low (temporary or 
insignificant) to High (death, loss of mission, or significant reduction to length or quality of life). 
Quantitative evidence from clinical, operational, and research sources were used whenever available. 
Qualitative evidence was used when quantitative evidence was unavailable. Expert opinion was used 
whenever insufficient evidence was available. Results: A set of 30 risks emerged that will require further 
mitigation efforts before being accepted by the Agency. The likelihood by consequence risk assessment 
process provided a means of prioritizing among the risks identified. For each of the high priority risks, a 
plan was developed to perform research, technology, or standards development thought necessary to 
provide suitable reduction of likelihood or consequence to allow agency acceptance. Conclusion: The 
HSRB process has successfully identified a complete set of risks to human space travellers on planned 
exploration missions based on the best evidence available today. Risk mitigation plans have been 
established for the highest priority risks. Each risk will be reassessed annually to track the progress of our 
risk mitigation efforts. 
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